Immunity of pregnancy: Novel concepts;Immunité de la gestation: Nouveaux concepts

Bulletin de l'Academie Nationale de Medecine

Volumn 193, Issue 5, 2009, Pages 1029-1042

  Le Bouteiller, Philippe ^a   El Costa, Hicham ^a   Aguerre Girr, Maryse ^a   Tabiasco, Julie ^a  

^a CHU PURPAN   (France)

Author keywords

Cytokines; Cytotoxicity; HLA antigens; Killer cells; Natural; Placenta; Trophoblasts

Indexed keywords

EID: 72449192838     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32494-x     Document Type: Article

References (48)

1. MEDAWAR P.B. -Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol,. 1953, 44, 320-338.
2. CAUCHETEUX S.M., C. KANELLOPOULOS-LANGEVIN, D.M. OJCIUS. -At the innate frontiers between mother and fetus: linking abortion with complement activation. Immunity, 2003,18, 169-172.
3. LEDEE-BATAILLE N. -Materno-fœetal dialogue and human embryo implantation: some evolving concepts. J. Gynecol. Obstet. Biol. Reprod, 2004, 33, 564-576.
4. CHAOUAT G. -The Th1/Th2 paradigm: still important in pregnancy? Semin. Immunopathol, 2007, 29, 95-113.
5. HUNT J.S. -Stranger in a strange land. Immunol. Rev., 2006, 213, 36-47.
6. MOFFETT A., C. LORE. -Immunology of placentation in eutherian mammals. Nat. Rev. Immuno, 2006, 6, 584-594.
7. [7] MOFFETT A., Y.W. LOkE.-The immunological paradox of pregnancy: a reappraisal. Placenta, 2004,25,1-8. (Pubitemid 38100760)
8. LE BOUTEILLER P., A. BLASCHITZ. -The functionality of HLA-G is emerging. Immunol. Rev., 1999, 167, 233-244.
9. LORE Y.W., A. KING. -Immunology of human placental implantation: clinical implications of our current understanding. Mol. Med Today, 1997, 3, 153-159.
10. LE BOUTEILLER P., J. PRÖLL.-Immunologie placentaire: le fœtus face à un double défi. Réalités en Gynécologie-Obstétrique,. 2001, 57, 9-17.
11. SOLIER C., M. AGUERRE-GIRR, F. LENFANT, A. CAMPAN, A. BERREBI, V. REBMANN, et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-Gl by human villous trophoblast. Eur. J. Immunol., 2002, 32, 3576-3586.
12. ISHITANI A., N. SAGESHIMA, N. LEE, N. DOROFEEVA, K. HATAKE, H. MARQUARDT, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol, 2003, 171, 1376-1384.
13. HUNT J.S., P.J. MORALES, J.L. PACE, A.T. FAZLEABAS, D.K. LANGAT. -A commentary on gestational programming and functions of HLA-G in pregnancy. Placenta, 2007,28 Suppl A, S57-63.
14. PRÖLL J., A. BENSUSSAN, F. GOFFIN, J.M. FOIDART, A. BERREBI, P. LE BOUTEILLER. -Tubal versus uterine placentation: similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens, 2000, 56, 479-491.
15. ZHANG J., D. SCHNEIDER, C. OBER, M.S. MCPEEK. -Multilocus linkage disequilibrium mapping by the decay of haplotype sharing with samples of related individuals. Genet. Epidemiol, 2005, 29, 128-140.
16. HOLMES C., K. SIMPSON, H. OKADA, N. OKADA, S. WAINWRIGHT, D. PURCELL, et al. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur. J. Immunol, 1992, 22, 1579-1585.
17. Xu C., D. MAO, V.M. HOLERS, B. PALANCA, A.M. CHENG, H. MOLINA. -A critical role for murine complement regulator crry in fetomaternal tolerance. Science, 2000,287,498-501.
18. GIRARDI G., R. BULLA, J.E. SALMON, F. TEDESCO. -The complement system in the pathophysiology of pregnancy. Mol. Immunol., 2006, 43, 68-77.
19. AÏT-AZZOUZENE D., M. GENDRON, M. HOUDAYER, A. LANGKOPF, K. BURKI, D. NEMAZEE, et al. - Maternal B lymphocytes specific for paternal histocompatibility antigens are partially deleted during pregnancy. J. Immunol, 1998,161.
20. HUNT J.S., D.E. GERAGHTY. -Soluble HLA-G isoforms: technical deficiencies lead to misinterpretations. Mol. Hum. Reprod, 2005, 11, 715-717.
21. CONTINI P., M. GHIO, A. POGGI, G. FILACI, F. INDIVERI, S. FERRONE, et al. -Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol., 2003, 33, 125-134.
22. ALEGRE E., A. DIAZ-LAGARES, J. LEMAOULT, N. LOPEZ-MORATALLA, E.D. CAROSELLA, A. GONZALEZ. -Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy. Hum. Immunol, 2007,68, 661-667.
23. HUNT J.S., L. JADHAV, W. CHU, D.E. GERAGHTY, C. OBER. -Soluble HLA-G circulates in maternal blood during pregnancy. Am. J. Obstet. Gynecol, 2000, 183, 682-688.
24. SLAGER H.G., W. VAN INZEN, E. FREUND, A.J. VAN DEN EIJNDEN-VAN RAAU, CL. MUMMERY. - Transforming growth factor-beta in the early mouse embryo: implications for the regulation of muscle formation and implantation. Dev Genet., 1993, 14, 212-224.
25. SZEKERES-BARTHO J., A. BARAKONYI, G. PAR, B. POLGAR, T. PALKOVICS, L. SZEREDAY. Progesterone as an immunomodulatory molecule. Int. Immunopharmacol, 2001, 1, 1037-1048.
26. [26] MUNN D.H., M. ZHOU, J.T. ATTWOOD, I. BONDAREV, S.J. CONWAY, B. MARSHALL, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science, 1998, 281, 1191-1193. (Pubitemid 28406294)
27. HUNT J.S., D. VASSMER, T.A. FERGUSON, L. MILLER. -Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol, 1997, 158, 4122-4128.
28. FOURNEL S., M. AGUERRE-GIRR, X. Hue, F. LENFANT, A. ALAM, A. TOUBERT, et al. -Cutting Edge: Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J. Immunol, 2000,164, 6100-6104.
29. TAFURI A., J. ALFERINK, P. MOLLER, G.J. HAMMERLING, B. ARNOLD. -T cell awareness of paternal alloantigens during pregnancy. Science, 1995, 270, 630-633.
30. JIANGS., M. VACCHIO. -Multiple mechanisms of peripheral T cell tolerance to the fetal allograft. J Immunol, 1998, 160, 3086-3090.
31. [31] BULMER J., G. LASH. -Human uterine natural killer cells: a reappraisal. Mol. Immunol., 2005, 42,511-521. (Pubitemid 39655962)
32. TABIASCO J., M. RABOT, M. AGUERRE-GIRR, H. EL COSTA, A. BERREBI, O. PARANT, et al. Human decidual NK cells: unique phenotype and functional properties -a review. Placenta, 2006,27 Suppl A, S34-39.
33. LE BOUTEILLER P., A. BARAKONYI, J. GIUSTINIANI, F. LENFANT, A. MARIE-CARDINE, M. AGUERRE-GIRR, et al. -Engagement of CD 160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl. Acad Sci. USA., 2002, 99, 16963-16968.
34. KOOPMAN L., H. KOPCOW, B. RYBALOV, J. BOYSON, J. ORANGE, F. SCHATZ, et al. -Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med, 2003,198, 1201-1212.
35. HANNA J., D. GOLDMAN-WOHL, Y. HAMANI, I. AVRAHAM, C. GREENFIELD, S. NATANSONYARON, et al. -Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med., 2006, 12, 1065-1074.
36. KOPCOW H.D., D.S. ALLAN, X. CHEN, B. RYBALOV, M.M. ANDZELM, B. GE, et al. -Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl. Acad Sci. USA., 2005,102, 15563-15568.
37. EL COSTA H., A. CASEMAYOU, M. AGUERRE-GIRR, M. RABOT, A. BERREBI, O. PARANT, et al. Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J. Immunol, 2008, 181, 3009-3017.
38. AVRIL T., A.C. JAROUSSEAU, H. WATIER, J. BOUCRAUT, P. LE BOUTEILLER, P. BARDOS, et al. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. I Immunol, 1999,162, 5902-5909. (Pubitemid 29314944)
39. CHUMBLEY G., A. KING, K. ROBERTSON, N. HOLMES, Y.W. LORE. -Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol., 1994,155, 312-322.
40. STRASZEWSKI-CHAVEZ S., V. ABRAHAMS, E. FUNAI, G. MOR. -X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol. Hum. Reprod, 2004, 10, 33-41.
41. HIBY S.E., J.J. WALKER, M. O'SHAUGHNESSY K, C.W. REDMAN, M. CARRINGTON, J. TROWSDALE, et al. -Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med, 2004,200, 957-965.
42. REDMAN C.W., I.L. SARGENT. -Latest advances in understanding preeclampsia. Science, 2005, 308, 1592-1594.
43. LE BOUTEILLER P., J. TABIASCO. -Killers become builders during pregnancy. Nature Medicine, 2006, 12, 991-992.
44. RAJAGOPALAN S., Y.T. BRYCESON, S.P. KUPPUSAMY, D.E. GERAGHTY, A.V. MEER, I. JOOSTEN, et al. -Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G. PLoS Biol, 2005,4, e9.
45. CROY B.A., H. HE, S. ESADEG, Q. WEI, D. MCCARTNEY, J. ZHANG, et al. -Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction, 2003,126,149-160.
46. GUIMOND M.J., B. WANG, B.A. CROY. -Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J. Exp. Med, 1998,187,217-223.
47. MOLD J.E., J. MICHAELSSON, T.D. BURT, M.O. MUNCH, K.P. BECKERMAN, M.P. BUSCH, et al. - Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science, 2008, 322, 1562-1565.
48. SASAKI Y., M. SAKAI, S. MIYAZAKI, S. HIGUMA, A. SHIOZAKI, S. SAITO. -Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod, 2004, 10, 347-353.